Burton RA, Joffe GM. Neonatal outcomes from a comprehensive prematurity prevention program. Disease Management1:65-75, 1998.
|
Byrnes J. Does disease management really work? The Lovelace Health Systems experience. Disease Management1:39-53, 1998.
|
Doxtator RF, Rodriguez DJ. Evaluating costs, benefits, and return on investment for disease management programs. Disease Management1:185-192, 1998.
|
Friedman NM, Gleeson JM, Kent MJ, Foris M, Rodriguez DJ, Cypress M. Management of diabetes mellitus in the Lovelace Health Systems' Episodes of Care® Program. Effective Clinical Practice 1:5-11, 1998.
|
Gillett T. Navigating the MCO Study Approval Process. Partnerships in Clinical Trials: Pharmaceutical Company and Managed Care Alliance 1998.
|
Gunter MJ. Episodes of Care®: The Lovelace Clinic experience with indicator assessment and implementation of changes in care. In: Healthcare Quality Indicators: A Practical Approach. P. Gross, S. Greenfield (eds), Blackwell Science, Ltd., 1998.
|
Gunter MJ. Episodes of Care®: The Lovelace Clinic experience with indicator assessment and implementation of changes in care. International Medical Forum 103:111-122, 1998.
|
Ichter JT. The link between disease management and capitation contracting: Financing population health. Disease Management 1:27-30, 1998.
|
Marosi A, Stiesmeyer JK, Faculjak PF. Setting up a multidisciplinary pediatric asthma Episodes of Care®: Results from a 1-year study. Disease Management1:3-12, 1998.
|
Sunderman H, Paez K. Time is tissue: Stroke management lessons from Lovelace. Strategic Medicine 2:15-20, 1998.
|